Embarking on the forefront of pharmacological innovation, drug formulation exemplifies a testament to ground-breaking science and precision. This pharmacological masterpiece redefines conventional boundaries in drug development, seamlessly integrating cutting-edge technology with nature-inspired ingredients. At the core of this pharmaceutical revolution is an unwavering commitment to rigorous research and development, ensuring that each formulation undergoes meticulous testing to validate its safety and efficacy. This dedication to scientific excellence propels the industry into a new era where innovation and patient well-being converge seamlessly.
The elegance of the liposomal drug delivery system ensures targeted impact, orchestrating a therapeutic ballet that navigates the intricate biological landscape with finesse. Beyond traditional pill-based solutions, drug design embraces unconventional formats, addressing not just symptoms but also the root cause of ailments. Furthermore, a relentless pursuit of sustainability echoes through every aspect of the drug formulation process.
Title : Development of novel drug delivery pathways enabled by perillyl alcohol (NEO100), A monoterpene with multifaceted biomedical applications
Axel H Schonthal, University of Southern California, United States
Title : From marker to mechanism: Ligand discovery enables functional analysis of OR51E1, an ectopic olfactory receptor, in prostate cancer
Vladlen Slepak, University of Miami, United States
Title : The impact of metal-decorated polymeric nanodots on proton relaxivity
Paulo Cesar De Morais, Catholic University of Brasilia, Brazil
Title : Hepatotoxic botanicals-shadows of pearls
Consolato M Sergi, University of Alberta, Canada
Title : Personalized and Precision Medicine (PPM) as a unique healthcare model based on design-inspired biotech- & biopharma-driven applications to secure the human healthcare and biosafety
Sergey Suchkov, N D Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences & InMedStar, Russian Federation
Title : R&D consultancy at the medicines discovery catapult: De-risking drug discovery for innovators
Adriana Gambardella, Medicine Discovery Catapult, United Kingdom
Title : Biocompatible synthesis of non crystalline iron oxide nanoparticles with stable colloidal properties
Lan Wang, Paretor LLC, United States
Title : Precision diagnostics: Effectiveness of innovative imaging technologies for early detection of lung cancers
Huiqin Yang, ICON Clinical Research Ltd, United Kingdom
Title : Principles and standards for managing healthcare transformation towards personalized, preventive, predictive, participative precision medicine ecosystems
Bernd Blobel, University of Regensburg, Germany
Title : Design and characterization of gum arabic buccal films for protein drug delivery
Krisztian Pamlenyi, University of Szeged, Hungary